Jiyoung Park Selected Research

Fibrosis (Cirrhosis)

1/2024	Ginkgo biloba extract ameliorates skin fibrosis in a bleomycin-induced mouse model of systemic sclerosis.
12/2022	Mitochondrial Peroxiredoxin III Protects against Non-Alcoholic Fatty Liver Disease Caused by a Methionine-Choline Deficient Diet.
1/2022	Radiotherapy-induced oxidative stress and fibrosis in breast cancer are suppressed by vactosertib, a novel, orally bioavailable TGF-β/ALK5 inhibitor.
10/2020	The impact of endotrophin on the progression of chronic liver disease.
1/2019	COL6A3-derived endotrophin links reciprocal interactions among hepatic cells in the pathology of chronic liver disease.
10/2017	The therapeutic effects of Yongdamsagan-tang on autoimmune hepatitis models.
1/2017	Endotrophin, a multifaceted player in metabolic dysregulation and cancer progression, is a predictive biomarker for the response to PPARγ agonist treatment.
9/2014	ERα upregulates Phd3 to ameliorate HIF-1 induced fibrosis and inflammation in adipose tissue.
3/2014	Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiyoung Park Research Topics

Disease

31	Neoplasms (Cancer) 03/2024 - 12/2010
19	Inflammation (Inflammations) 03/2023 - 09/2007
14	Breast Neoplasms (Breast Cancer) 12/2023 - 12/2010
14	Obesity 01/2023 - 08/2003
14	Insulin Resistance 01/2023 - 08/2003
9	Fibrosis (Cirrhosis) 01/2024 - 03/2014
8	Type 2 Diabetes Mellitus (MODY) 09/2019 - 06/2007
5	Non-alcoholic Fatty Liver Disease 01/2023 - 07/2016
5	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2010
4	Hyperglycemia 01/2023 - 12/2012
4	Infections 01/2022 - 11/2007
3	Fatty Liver 01/2023 - 01/2016
3	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2014
2	Xeroderma Pigmentosum (Kaposi's Disease) 03/2024 - 07/2023
2	Stroke (Strokes) 11/2023 - 08/2023
2	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 11/2021
2	Melanoma (Melanoma, Malignant) 12/2022 - 04/2021
2	Metabolic Diseases (Metabolic Disease) 01/2022 - 01/2021
2	Asthma (Bronchial Asthma) 01/2021 - 01/2016
2	Liver Diseases (Liver Disease) 10/2020 - 01/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2016 - 02/2014
1	Systemic Scleroderma (Systemic Sclerosis) 01/2024
1	Hemorrhage 10/2023
1	Anorexia 01/2023
1	Dementia (Dementias) 01/2023
1	Lethargy 01/2023
1	Cough 01/2023
1	Abscess 01/2023
1	Carcinosarcoma 01/2023

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2014
11	endotrophinIBA 01/2023 - 11/2012
7	Biomarkers (Surrogate Marker)IBA 03/2023 - 01/2016
7	LipidsIBA 01/2022 - 06/2005
6	Interleukin-6 (Interleukin 6)IBA 05/2022 - 04/2014
6	CytokinesIBA 04/2022 - 11/2006
5	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2023 - 11/2017
5	Glucose (Dextrose)FDA LinkGeneric 05/2019 - 05/2004
4	TensinsIBA 01/2023 - 11/2017
4	Peptides (Polypeptides)IBA 01/2023 - 10/2020
4	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2022 - 03/2011
4	CollagenIBA 01/2021 - 11/2012
3	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 11/2020
3	Neutralizing AntibodiesIBA 12/2023 - 01/2019
3	Neuregulin-1 (Neuregulin 1)IBA 01/2023 - 12/2012
3	Peroxiredoxin IIIIBA 12/2022 - 01/2019
3	Nonesterified Fatty Acids (NEFA)IBA 12/2022 - 07/2016
3	Messenger RNA (mRNA)IBA 05/2022 - 12/2012
3	AntibodiesIBA 01/2022 - 10/2017
3	Insulin (Novolin)FDA Link 10/2021 - 10/2016
3	LigandsIBA 09/2019 - 06/2007
3	EnzymesIBA 11/2017 - 09/2007
3	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2017 - 12/2015
3	AdipokinesIBA 08/2011 - 06/2005
2	Collagen Type VIIBA 01/2023 - 10/2020
2	Amyloid (Amyloid Fibrils)IBA 01/2023 - 11/2021
2	AntioxidantsIBA 12/2022 - 08/2021
2	Methionine (L-Methionine)FDA Link 12/2022 - 12/2021
2	PeroxiredoxinsIBA 12/2022 - 08/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2022 - 01/2020
2	AntigensIBA 12/2022 - 04/2021
2	SuspensionsIBA 12/2022 - 04/2021
2	Fibronectins (Fibronectin)IBA 01/2022 - 01/2022
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 10/2017
2	vactosertibIBA 01/2022 - 01/2022
2	Therapeutic UsesIBA 12/2021 - 10/2017
2	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2019
2	HDL CholesterolIBA 01/2021 - 08/2020
2	Translationally-Controlled 1 Tumor ProteinIBA 01/2021 - 01/2021
2	C-Reactive ProteinIBA 01/2021 - 08/2020
2	Indicators and Reagents (Reagents)IBA 08/2020 - 01/2019
2	Chemotactic FactorsIBA 01/2019 - 01/2017
2	Leptin ReceptorsIBA 08/2011 - 12/2010
2	LeptinIBA 08/2011 - 12/2010
2	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 04/2008 - 06/2005
1	indium-bleomycinIBA 01/2024
1	Ginkgo biloba extract (Rokan)IBA 01/2024
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2024
1	Warfarin (Coumadin)FDA LinkGeneric 10/2023
1	DNA (Deoxyribonucleic Acid)IBA 07/2023
1	Transcription Factors (Transcription Factor)IBA 07/2023
1	LY 290181IBA 07/2023
1	Twist-Related Protein 1IBA 07/2023
1	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 01/2023
1	Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA 01/2023
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2023
1	Lapatinib (GW572016)FDA Link 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Streptozocin (Streptozotocin)FDA Link 01/2023
1	EstersIBA 01/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2023
1	Carrier Proteins (Binding Protein)IBA 01/2023
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 12/2022
1	Choline (Choline Chloride)IBA 12/2022

Therapy/Procedure

11	Therapeutics 01/2024 - 06/2011
2	Drug Therapy (Chemotherapy) 03/2024 - 07/2023
2	Radiotherapy 01/2022 - 01/2022
2	Splenectomy 11/2020 - 11/2018
1	Stroke Rehabilitation 11/2023
1	Activities of Daily Living (ADL) 08/2023
1	Canes (Cane) 01/2023